Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
NCT00438113
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
184
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Aggressive Blood Pressure control
Sponsor
Nova Scotia Health Authority
Collaborators
[object Object]